Onset of vitiligo in a psoriasis patient on ixekizumab-Reference-Cited by-同舟云学术

Onset of vitiligo in a psoriasis patient on ixekizumab

Published:2021-09 Issue:5 Volume:34 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Marasca Claudio¹^ORCID,Fornaro Luigi¹,Martora Fabrizio¹,Picone Vincenzo¹,Fabbrocini Gabriella¹^ORCID,Megna Matteo¹^ORCID

Affiliation:

1. Section of Dermatology, Department of Clinical Medicine and Surgery University of Naples Federico II Napoli Italy

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15102

Reference13 articles.

1. Low dose oral corticosteroids, microneedling, and topical 5‐fluorouracil: A novel treatment for recalcitrant pediatric vitiligo

2. Ixekizumab: An efficacious treatment for both psoriasis and hidradenitis suppurativa

3. Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview

4. Secukinumab and hidradenitis suppurativa: Friends or foes?

5. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross‐sectional study;Canu D;J Eur Acad Dermatol Venereol,2021

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of Cytokines and Chemokines in Vitiligo and Their Therapeutic Implications;Journal of Clinical Medicine;2024-08-20

2. A narrative review of the literature: The role of biologics and JAK inhibitors in vitiligo;Australasian Journal of Dermatology;2024-08

3. Mechanistic Investigation of WWOX Function in NF-kB-Induced Skin Inflammation in Psoriasis;International Journal of Molecular Sciences;2023-12-21

4. Guselkumab-induced vitiligo in a patient with psoriatic arthritis;JAAD Case Reports;2023-11

5. Optimization of secukinumab dose regimens in patients with moderate-to-severe plaque psoriasis via exposure-response modeling;Expert Review of Clinical Pharmacology;2023-09-22